Impaired TGF-β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes.

Wound healing (WH) impairment is a well-documented phenomenon in clinical and experimental diabetes. Sex hormones, in addition to a number of signaling pathways including transforming growth factor-β1 (TGF-β1)/Smads and TNF-α/NF-κB in macrophages and fibroblasts, appear to play a cardinal role in determining the rate and nature of WH. We hypothesized that a defect in resolution of inflammation and an enhancement in TNF-α/NF-κB activity induced by estrogen deficiency contribute to the impairment of TGF-β signaling and delayed WH in diabetes models. Goto-Kakizaki (GK) rats and full thickness excisional wounds were used as models for type 2 diabetes (T2D) and WH, respectively. Parameters related to the various stages of WH were assessed using histomorphometry, western blotting, real-time PCR, immunofluorescence microscopy and ELISA-based assays. Retarded re-epithelialization, suppressed angiogenesis, delayed wound closure, reduced estrogen level and heightened states of oxidative stress were characteristic features of T2D wounds. These abnormalities were associated with a defect in resolution of inflammation, shifts in macrophage phenotypes, increased β3-integrin expression, impaired wound TGF-β1 signaling (↓p-Smad2/↑Smad7) and enhanced TNF-α/NFκB activity. Human/rat dermal fibroblasts of T2D, compared to corresponding control values, displayed resistance to TGF-β-mediated responses including cell migration, myofibroblast formation and p-Smad2 generation. A pegylated form of soluble TNF receptor-1 (PEG-sTNF-RI) or estrogen replacement therapy significantly improved re-epithelialization and wound contraction, enhanced TGFβ/Smad signaling, and polarized the differentiation of macrophages toward an M2 or "alternatively" activated phenotype, while limiting secondary inflammatory-mediated injury. Our data suggest that reduced estrogen levels and enhanced TNF-α/NF-κB activity delayed WH in T2D by attenuating TGFβ/Smad signaling and impairing the resolution of inflammation; most of these defects were ameliorated with estrogen and/or PEG-sTNF-RI therapy.

[1]  J. Albina,et al.  The phenotype of murine wound macrophages , 2010, Journal of leukocyte biology.

[2]  D. Graves,et al.  Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1) , 2010, Diabetologia.

[3]  D. Laskin.  Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. , 2009, Chemical research in toxicology.

[4]  G. Ashcroft,et al.  Unique and synergistic roles for 17beta-estradiol and macrophage migration inhibitory factor during cutaneous wound closure are cell type specific. , 2009, Endocrinology.

[5]  P. Fernández-Salguero,et al.  Loss of dioxin-receptor expression accelerates wound healing in vivo by a mechanism involving TGFβ , 2009, Journal of Cell Science.

[6]  C. Pilapil,et al.  Interleukin‐1β and tumor necrosis factor α inhibit chondrogenesis by human mesenchymal stem cells through NF‐κB–dependent pathways , 2009 .

[7]  Sarah L. Brown,et al.  Efficient colonic mucosal wound repair requires Trem2 signaling , 2009, Proceedings of the National Academy of Sciences.

[8]  G. Ashcroft,et al.  Effect of estrogen and progesterone on macrophage activation during wound healing , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[9]  H. van Goor,et al.  Macrophage diversity in renal injury and repair. , 2008, The Journal of clinical investigation.

[10]  P. Pozzilli,et al.  Menarche in type 1 diabetes is still delayed despite good metabolic control. , 2008, Fertility and sterility.

[11]  Yunliang Chen,et al.  Loss of protein kinase Cϵ results in impaired cutaneous wound closure and myofibroblast function , 2008, Journal of Cell Science.

[12]  R. Roeder,et al.  Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia , 2008, The Journal of Experimental Medicine.

[13]  Xuan Cheng,et al.  Accelerated re-epithelialization in Dpr2-deficient mice is associated with enhanced response to TGFβ signaling , 2008, Journal of Cell Science.

[14]  Matthias Schäfer,et al.  Cancer as an overhealing wound: an old hypothesis revisited , 2008, Nature Reviews Molecular Cell Biology.

[15]  Vandana Iyer,et al.  alpha3beta1 integrin-controlled Smad7 regulates reepithelialization during wound healing in mice. , 2008, The Journal of clinical investigation.

[16]  G. Ashcroft,et al.  Selective estrogen receptor modulators accelerate cutaneous wound healing in ovariectomized female mice. , 2008, Endocrinology.

[17]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[18]  S. Jimenez,et al.  Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes. , 2007, Osteoarthritis and cartilage.

[19]  Jun Asai,et al.  Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. , 2007, The American journal of pathology.

[20]  T. Krieg,et al.  Inflammation in wound repair: molecular and cellular mechanisms. , 2007, The Journal of investigative dermatology.

[21]  Andrea M A Costa,et al.  Overweight induced by high-fat diet delays rat cutaneous wound healing , 2006, British Journal of Nutrition.

[22]  S. Ghosh,et al.  NF-κB and the immune response , 2006, Oncogene.

[23]  K. Matsushima,et al.  Absence of IL-1 Receptor Antagonist Impaired Wound Healing along with Aberrant NF-κB Activation and a Reciprocal Suppression of TGF-β Signal Pathway1 , 2006, The Journal of Immunology.

[24]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[25]  Paul Martin,et al.  Inflammatory cells during wound repair: the good, the bad and the ugly. , 2005, Trends in cell biology.

[26]  F. Al-Mulla,et al.  Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes. , 2005, Life sciences.

[27]  G. Schultz,et al.  Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. , 2005, Diabetes care.

[28]  R. Hynes,et al.  Accelerated re-epithelialization in β3-integrin-deficient- mice is associated with enhanced TGF-β1 signaling , 2005, Nature Medicine.

[29]  Hong-Jian Zhu,et al.  Differential regulation of VEGF by TGF-beta and hypoxia in rat proximal tubular cells. , 2004, American journal of physiology. Renal physiology.

[30]  F. Al-Mulla,et al.  α-lipoic Acid Mitigates Insulin Resistance in Goto-Kakizaki Rats , 2004 .

[31]  M. Jinnin,et al.  Antagonistic Effects of TNF-α on TGF-β Signaling Through Down-Regulation of TGF-β Receptor Type II in Human Dermal Fibroblasts1 , 2003, The Journal of Immunology.

[32]  T. Hunt,et al.  Multiple Organ Engraftment by Bone‐Marrow‐Derived Myofibroblasts and Fibroblasts in Bone‐Marrow‐Transplanted Mice , 2003, Stem cells.

[33]  M. Horan,et al.  Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. , 2003, The Journal of clinical investigation.

[34]  H. Werner,et al.  The IGFI receptor gene: A molecular target for disrupted transcription factors , 2003, Genes, chromosomes & cancer.

[35]  G. Ashcroft,et al.  Androgen receptor-mediated inhibition of cutaneous wound healing. , 2002, The Journal of clinical investigation.

[36]  C. Hill,et al.  Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. , 2002, Molecular cell.

[37]  N. Mukaida,et al.  Accelerated wound healing in tumor necrosis factor receptor p55‐deficient mice with reduced leukocyte infiltration , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  D. Goeddel,et al.  TNF-R1 Signaling: A Beautiful Pathway , 2002, Science.

[39]  F. Verrecchia,et al.  Transforming Growth Factor-β Signaling Through the Smad Pathway: Role in Extracellular Matrix Gene Expression and Regulation , 2002 .

[40]  D. Granger,et al.  Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[41]  Liliana Attisano,et al.  Synergistic Cooperation between Hypoxia and Transforming Growth Factor-β Pathways on Human Vascular Endothelial Growth Factor Gene Expression* , 2001, The Journal of Biological Chemistry.

[42]  M. Bitar.  Co-Administration of Etomoxir and RU-486 Mitigates Insulin Resistance in Hepatic and Muscular Tissues of STZ-Induced Diabetic Rats , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[43]  J. Raemaekers,et al.  A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR. , 2001, The Journal of molecular diagnostics : JMD.

[44]  J. Massagué,et al.  How cells read TGF-β signals , 2000, Nature Reviews Molecular Cell Biology.

[45]  J. Pfeilschifter,et al.  Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. , 2000, The Journal of investigative dermatology.

[46]  M. Bitar.  Insulin and glucocorticoid-dependent suppression of the IGF-I system in diabetic wounds. , 2000, Surgery.

[47]  E. Bottinger,et al.  A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA , 2000, Genes & Development.

[48]  J. Massagué.  How cells read TGF-beta signals. , 2000, Nature reviews. Molecular cell biology.

[49]  H. Kleinman,et al.  Impaired wound repair and delayed angiogenesis in aged mice. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[50]  A. Singer,et al.  Cutaneous wound healing. , 1999, The New England journal of medicine.

[51]  J. Wolf,et al.  Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats , 1999, Inflammation Research.

[52]  M. Bitar,et al.  Glucocorticoid-dependent impairment of wound healing in experimental diabetes: amelioration by adrenalectomy and RU 486. , 1999, The Journal of surgical research.

[53]  E. Middelkoop,et al.  Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. , 1998, The Journal of investigative dermatology.

[54]  Bitar Ms.  Glucocorticoid dynamics and impaired wound healing in diabetes mellitus. , 1998 .

[55]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[56]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[57]  M. Krönke,et al.  TNF-induced activation of NF-kappa B. , 1995, Immunobiology.

[58]  J. Davidson,et al.  Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. , 1991, The Journal of investigative dermatology.

[59]  P. Hebda,et al.  Stimulatory effects of transforming growth factor-beta and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures. , 1988, The Journal of investigative dermatology.

[60]  A. Fabiato,et al.  Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. , 1983, The American journal of physiology.

[61]  Y. Gotō,et al.  Production of spontaneous diabetic rats by repetition of selective breeding. , 1976, The Tohoku journal of experimental medicine.

[62]  J. F. Woessner,et al.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. , 1961, Archives of biochemistry and biophysics.